US and Chinese stocks experienced gains amid anticipation for US-China trade discussions and the Federal Reserve's ...

LONDON — Stock markets diverged and the dollar rose on Wednesday as investors awaited an upcoming interest rate decision by the US Federal Reserve and looming trade talks between China and the United ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

As AI strategies come into focus, companies are shifting from finding efficiencies to revenue growth and innovation ...

Frederick "Derick" Cooper, CEO of QOL Medical, a biopharmaceutical company specializing in treatments for rare gastrointestinal diseases, has donated $50,000 to Beacon Rescue, a nonprofit Search and ...

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...

This paper explores innovations in HVAC (Heating, Ventilation, and Air Conditioning) systems, highlighting the shift toward sustainable and eco-efficient solutions, with an emphasis on renewable ...

For instance, Novo Nordisk’s Rare Disease group ... “You don't do a big launch and then fire and forget. Every year, you launch new, small indications.” Helfgott says that, while it might ...

Novo Nordisk reports its results in Danish kroner (DKK) rather than U.S. dollars. Sales grew 19% year over year to 78.1 ...

BAGSVAERD, Denmark (AP) — BAGSVAERD, Denmark (AP) — Novo Nordisk A/S (NVO) on Wednesday reported first-quarter earnings of $4.09 billion. The Bagsvaerd, Denmark-based company said it had profit of 92 ...

Novo Nordisk saw a significant decline as it lost over 55% from its highs in June 2024. Check out the reasons for the decline ...